Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2020 2020-07-03
INSIDE INFORMATION ANNOUNCEMENT - COMPLETION OF PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER 2020-06-16
INSIDE INFORMATION ANNOUNCEMENT - PLACING OF EXISTING SHARES BY CONTROLLING SHAREHOLDER 2020-06-12
VOLUNTARY ANNOUNCEMENT - CO-DEVELOPMENT OF ANTIBODY FOR CORONAVIRUS TREATMENT WITH INSTITUT PASTEUR OF SHANGHAI 2020-06-10
VOLUNTARY ANNOUNCEMENT - STRATEGIC COLLABORATION WITH SANOFI ON KN026 IN HER2+ BREAST CANCER 2020-06-09
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2020 2020-06-02
VOLUNTARY ANNOUNCEMENT - COLLABORATION AGREEMENT OF ANTI-TUMOR COMBINATION THERAPY WITH SLP 2020-05-28
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON MAY 25, 2020 2020-05-25
Next Day Disclosure Return 2020-05-21
VOLUNTARY ANNOUNCEMENT - ABSTRACTS ON USING TRANSLATIONAL TGI MODEL AND POPULATION PK ANALYSIS FOR KN026 ACCEPTED FOR POSTER PRESENTATION AT 2020 AACR ANNUAL MEETING 2020-05-18

20 21 22 23 24 25 26